Disinfectants for the decontamination of surfaces and dental instruments during the COVID-19 pandemic
DOI:
https://doi.org/10.32480/rscp.2021.26.2.1185Keywords:
COVID-19, betacoronavirus, disinfectionAbstract
Progress has been made in the knowledge of the characteristics and behavior of COVID-19, which should be used by health professionals in order to protect their patients and themselves. The objective of this updated review of the literature was to inform about the disinfectants that can be used to disinfect surfaces and instruments in the dental office. An electronic exploration was carried out to select scientific information in PubMed through the NCBI, Virtual Health Library and in databases SciELO, Redalyc, Dialnet, Latindex, Cochrane Library, LILACS and academic repositories, the information used included review articles, original articles and theses related to SARS-CoV-2/COVID-19 and disinfectants during the period January 2019 to January 2021, also considering some relevant articles on disinfection, from previous years.
Metrics
Downloads
References
(1) Phan T. Genetic diversity and evolution of SARS-CoV-2. Infect Genet Evol. 2020;81:104260.
(2) World Health Organization [Internet]. Geneva: World Health Organization; 2021 [Acceso 03 de junio de 2021]. Coronavirus disease (COVID-19) pandemic; [aprox 6 p]. Disponible en: https://www.who.int/emergencies/diseases/novel-coronavirus-2019
(3) Matos-Alviso LJ, Reyes-Gómez U, Comas-García A, Luévanos-Velásquez A, Reyes-Hernández KL, Guerrero-Becerra M, et al. Infecciones por coronavirus y el nuevo COVID-19: conceptos básicos. Rev Sal Jal. 2020;7(1):9-14.
(4) Moreno M, Silva L, Ramos P, Ávila I, Vázquez M, Vicent G, et al. Odontología en entorno COVID-19. Adaptación de las unidades de salud bucodental en los centros de salud de la comunidad de Madrid. Rev Esp Salud Pública. 2020;94.
(5) Pérez M, Gómez J, Dieguez R. Características clínico-epidemiológicas de la COVID-19. Rev Haban Cienc Méd. 2020;19(2):e3254.
(6) Aguilar V, Febres V. Actitud ante la COVID-19 en la práctica dental rutinaria. Rev Ciencias Médicas. 2020;24(3):e4463.
(7) Hamed MA. Una visión general sobre COVID-19: realidad y expectativa. Bull Natl Res Cent. 2020 junio;44:86.
(8) Palacios Cruz M, Santos E, Velázquez Cervantes MA, León Juárez M. COVID-19, a worldwide public health emergency. Rev Clin Esp. 2020 Mar 20;221(1):55-61. Disponible en: 10.1016/j.rce.2020.03.001.
(9) Contini C, Di Nuzzo M, Barp N, Bonazza A, De Giorgio R, Tognon M, et al. The novel zoonotic COVID-19 pandemic: An expected global health concern. J Infect Dev Ctries. 2020;14(3):254-264. Disponible en: 10.3855/jidc.12671
(10) Diomedi A, Chacón E, Delpiano L et al. Antisépticos y desinfectantes: apuntando al uso racional. Recomendaciones del comité consultivo de infecciones asociadas a la atención de salud, sociedad chilena de infectología. Rev Chil Infectol. 2017;34(2):156-174. Disponible en: 10.4067/S0716-10182017000200010.
(11) Talavera I, Menéndez A. Una explicación desde la química: ¿por qué son efectivos el agua y jabón, el hipoclorito de sodio y el alcohol para prevenir el contagio con la COVID-19? Anales de la Academia de Ciencias de Cuba [Internet]. 2020 [Acceso 15 de enero 2021]; 10(2):[aprox. 0 p.]. Disponible en: http://www.revistaccuba.sld.cu/index.php/revacc/article/view/781
(12) Kampf G, Todt D, Pfaender S, Steinmann E. Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents. J Hosp Infect. 2020;104(3):246-251. Disponible en: 10.1016/j.jhin.2020.01.022.
(13) Sánchez F, Furuya A, Arroniz P, et al. Comparación de la acción bactericida de hipoclorito de sodio y microcyn 60. Rev Odont Mex. 2009;13(1):9-16.
(14) Sacoto A. Protocolos de bioseguridad en odontología frente a COVID-19. Tesis [Internet]. 2020-10 [Acceso 13 de enero de 2021]. Disponible en: http://repositorio.ug.edu.ec/handle/redug/49680
(15) Spicciarelli V, Marruganti C, Viviano M, Baldini N, Franciosi G, Tortoriello M, et al. Prevention and safety in the dental office after novel human coronavirus outbreak: unresolved questions and future directions. J Osseointegr. 2020;12(2):145153. Disponible en: 10.23805 /JO.2020.12.01.11
(16) Silva Almerón JV, Veliz Duarte YJ. Eficacia del glutaraldehído al 2% frente al proceso de desinfección de alto nivel. Tesis [Internet]. [Consultado el 13 de enero de 2021]. [Lima]: Facultad de Ciencias de la Salud, Universidad Privada Norbert Wiener; 2018. Disponible en: http://repositorio.uwiener.edu.pe/bitstream/handle/123456789/2373/ESPECIALIDAD%20-%20SILVA%20-%20VELIZ.pdf?sequence=1&isAllowed=y
(17) Bizzoca ME, Campisi G, Lo Muzio L. COVID-19 pandemic: what changes for dentists and oral medicine experts? a narrative review and novel approaches to infection containment. International Journal of Environmental Research and Public Health. 2020;17(11):3793. doi:10.3390/ijerph17113793
(18) ChemicalSafetyFacts.org [Internet]. Washington DC: American Chemistry Council; 2021 [Acceso 13 de enero de 2021]. Formaldehído; [aprox 4 p]. Disponible en: https://www.chemicalsafetyfacts.org/es/formaldehido/
(19) Parra E, Zapata J. El formol. Su génesis, normas, aplicaciones e incidencia sobre la salud humana. Med UPB. 1999;18(1):35-45.
(20) López M, Ramis G, Pallarés FJ. Puesta a punto de una técnica inmunohistoquímica frente al virus influenza porcino. An Vet (Murcia). 2017;33:105.
(21) González L. Antisépticos y desinfectantes. Offarm. 2003;22(3):64-70.
(22) Figuero E, Herrera D, Tobias A, Serrano J, Roldan S, Escribano M, et al. Efficacy of adjunctive anti-plaque chemical agents in managing gingivitis: a systematic review and network metaanalyses. J Clin Periodontol. 2019; 46(7):723-739.
(23) Herrera D, Roldan S, Santacruz I, Santos S, Masdevall M, Sanz M. Differences in antimicrobial activity of four commercial 0.12% chlorhexidine mouthrinse formulations: an in vitro contact test and salivary bacterial counts study. J Clin Periodontol. 2003;30(4):307–314.
(24) Roldan S, Winkel EG, Herrera D, Sanz M, Van Winkelhoff AJ. The effects of a new mouthrinse containing chlorhexidine, cetylpyridinium chloride and zinc lactate on the microflora of oral halitosis patients: a dual-centre, double-blind placebo-controlled study. J Clin Periodontol. 2003;30(5):427-434.
(25) China National Health Commission. Chinese Clinical Guidance for COVID-19 Pneumonia Diagnosis and Treatment. 7th ed. Beijing, China: China National Health Commission; 2020 [Acceso 4 de mayo 2020]. Disponible en: http://kjfy.meetingchina.org/msite/news/show/cn/3337.htm
(26) Escribano M, Herrera D, Morante S, Teughels W, Quirynen M, Sanz M. Efficacy of a low-concentration chlorhexidine mouth rinse in non-compliant periodontitis patients attending a sup- portive periodontal care programme: a randomized clinical trial. J Clin Periodontol. 2010;37(3):266–275.
(27) Herrera D, Serrano J, Rolda?n S, Sanz M. Is the oral cavity relevant in sars-cov-2 pandemic? Clin Oral Investig. 2020;24(8):2925-2930.
(28) Ren YF, Rasubala L, Malmstrom H, Eliav E. Dental care and oral health under the clouds of COVID-19. JDR Clin Trans Res. 2020;5(3):202-210.
(29) Addy M, Wright R. Comparison of the in vivo and in vitro antibacterial properties of providone iodine and chlorhexidine glu- conate mouthrinses. J Clin Periodontol. 1978;5(3):198-205.
(30) Eggers M, Koburger-Janssen T, Ward LS, Newby C, Muller S. Bactericidal and virucidal activity of povidone-iodine and chlorhexidine gluconate cleansers in an in vivo hand hygiene clinical simulation study. Infect Dis Ther. 2018;7(2):235-247.
(31) Eggers M, Koburger-Janssen T, Eickmann M, Zorn J. In vitro bactericidal and virucidal efficacy of povidone-iodine gargle/mouthwash against respiratory and oral tract pathogens. Infect Dis Ther. 2018;7(2):249-259.
(32) Costa X, Laguna E, Herrera D, Serrano J, Alonso B, Sanz M. Efficacy of a new mouth rinse formulation based on 0.07% cetylpyridinium chloride in the control of plaque and gingivitis: a 6-month randomized clinical trial. J Clin Periodontol. 2013;40(11):1007-1015.
(33) Health Quality Ontario. Portable ultraviolet light surfacedisinfecting devices for prevention of hospital-acquired infections: a health technology assessment. Ont Health Technol Assess Ser. 2018;18(1):1-73.
(34) Darnell ME, Subbarao K, Feinstone SM, Taylor DR. Inactivation of the coronavirus that induces severe acute respiratory syndrome, SARS-CoV. J Virol Methods. 2004;121(1):85–91.
(35) Heßling M, Hönes K, Vatter P, Lingenfelder C. Ultraviolet irradiation doses for coronavirus inactivation - review and analysis of coronavirus photoinactivation studies. GMS Hyg Infect Control. 2020;15:Doc08. Disponible en: 10.3205/dgkh000343.
Downloads
Published
Issue
Section
License
Copyright (c) 2021 Revista de la Sociedad Científica del Paraguay
This work is licensed under a Creative Commons Attribution 4.0 International License.
El/los autores autorizan a la Revista de la Sociedad Científica del Paraguay a publicar y difundir el articulo del cual son autores, por los medios que considere apropiado.
